{"filing":{"accession_number":"0001213900-26-070378","cik":"0001676047","ticker":"NTRBW","company_name":"NutriBand Inc.","form":"8-K","filing_date":"2026-06-22","report_date":null,"primary_document":"ea0295410-8k_nutriband.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1676047/000121390026070378/ea0295410-8k_nutriband.htm"},"events":[{"id":12610,"run_id":11185,"accession_number":"0001213900-26-070378","anchor_item_number":"1.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"NutriBand entered into an amended $5,000,000 credit line facility on June 1, 2026, replacing an expiring facility from March 2023. This constitutes creation of a new direct financial obligation—a credit facility amendment—which is a material debt issuance event. The facility provides critical financing for the company's lead product through FDA approval and commercial manufacturing, making it material to investors assessing the registrant's capital structure and operational runway.","company_name":"NutriBand Inc.","ticker":"NTRBW","filing_date":"2026-06-22","form":"8-K","submitted_at":null,"items":[{"id":9511,"accession_number":"0001213900-26-070378","item_number":"1.01","item_title":"Entry into a Material","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"NutriBand entered into an amended $5,000,000 credit line facility on June 1, 2026, replacing an expiring facility from March 2023. This constitutes creation of a new direct financial obligation—a credit facility amendment—which is a material debt issuance event. The facility provides critical financing for the company's lead product through FDA approval and commercial manufacturing, making it material to investors assessing the registrant's capital structure and operational runway.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T12:05:06.181857+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9511,"accession_number":"0001213900-26-070378","item_number":"1.01","item_title":"Entry into a Material","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"NutriBand entered into an amended $5,000,000 credit line facility on June 1, 2026, replacing an expiring facility from March 2023. This constitutes creation of a new direct financial obligation—a credit facility amendment—which is a material debt issuance event. The facility provides critical financing for the company's lead product through FDA approval and commercial manufacturing, making it material to investors assessing the registrant's capital structure and operational runway.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-22T12:05:06.181857+00:00","company_name":"NutriBand Inc.","ticker":"NTRBW","filing_date":"2026-06-22"}]}